Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 19,178 shares at $17.29 ($332K) on 2024-02-13, disclosed to the SEC on 2024-02-15.
Seasonal sale ($332k) by President and CEO — this insider has traded DNLI in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.29 | 9,589 | $166K | 50.0% |
| 2 | $17.29 | 9,589 | $166K | 50.0% |
| Total | $17.29 avg | 19,178 | $332K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |